2,188
Views
33
CrossRef citations to date
0
Altmetric
Research Paper

Exome sequencing and digital PCR analyses reveal novel mutated genes related to the metastasis of pancreatic ductal adenocarcinoma

, , , , , , , , , , & show all
Pages 871-879 | Received 26 Dec 2011, Accepted 22 May 2012, Published online: 01 Aug 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Yifan Wang, Jun Yi & Xiaowei Liu. (2022) Roles of Dclk1 in the pathogenesis, diagnosis, prognosis and treatment of pancreatic cancer: A review. Expert Review of Gastroenterology & Hepatology 16:1, pages 13-19.
Read now
Sudhir Perincheri & Pei Hui. (2015) KRAS mutation testing in clinical practice. Expert Review of Molecular Diagnostics 15:3, pages 375-384.
Read now
Hassan Adwan, Ahmed Murtaja, Khamael Kadhim Al-Taee, Asim Pervaiz, Thomas Hielscher & Martin R Berger. (2014) Riproximin’s activity depends on gene expression and sensitizes PDAC cells to TRAIL. Cancer Biology & Therapy 15:9, pages 1185-1197.
Read now

Articles from other publishers (30)

Charbel Akkawi, Jerome Feuillard, Felipe Leon Diaz, Khalid Belkhir, Nelly Godefroy, Jean-Marie Peloponese, Marylene Mougel & Sebastien Laine. (2023) Murine leukemia virus (MLV) P50 protein induces cell transformation via transcriptional regulatory function. Retrovirology 20:1.
Crossref
Jinghao Lei, Qiang Wang, Tengfei Qu, Lichao Cha, Hanxiang Zhan, Jianwei Xu, Shanglong Liu, Lantian Tian, Chuandong Sun, Jingyu Cao, Fabo Qiu, Weidong Guo & Bin Zhou. (2023) KCNH2 regulates the growth and metastasis of pancreatic cancer. Journal of Pancreatology 6:3, pages 101-109.
Crossref
Eric Huntzinger, Jordan Sinteff, Bastien Morlet & Bertrand Séraphin. (2023) HELZ2: a new, interferon-regulated, human 3′-5′ exoribonuclease of the RNB family is expressed from a non-canonical initiation codon. Nucleic Acids Research.
Crossref
Amirhossein Davoodvandi, Mahdi Rafiyan, Zatollah Asemi & Seyed Amirhassan Matini. (2023) An epigenetic modulator with promising therapeutic impacts against gastrointestinal cancers: A mechanistic review on microRNA-195. Pathology - Research and Practice 248, pages 154680.
Crossref
Michela Roberto, Giulia Arrivi, Mattia Alberto Di Civita, Giacomo Barchiesi, Emanuela Pilozzi, Paolo Marchetti, Daniele Santini, Federica Mazzuca & Silverio Tomao. (2023) The role of CXCL12 axis in pancreatic cancer: New biomarkers and potential targets. Frontiers in Oncology 13.
Crossref
Juying Jiao, Chien-shan Cheng, Panling Xu, Peiwen Yang, Ke Zhang, Yanhua Jing & Zhen Chen. (2022) Mechanisms of pancreatic tumor suppression mediated by Xiang-lian pill: An integrated in silico exploration and experimental validation. Journal of Ethnopharmacology 298, pages 115586.
Crossref
Qin Lu, Hailan Feng, Hong Chen, Nathaniel Weygant, Jian Du, Zixing Yan & Zhiyun Cao. (2022) Role of DCLK1 in oncogenic signaling (Review). International Journal of Oncology 61:5.
Crossref
Xuanjin Zhu, Weilu Jia, Yong Yan, Yong Huang & Bailin Wang. (2021) NOP14 regulates the growth, migration, and invasion of colorectal cancer cells by modulating the NRIP1/GSK-3β/β-catenin signaling pathway. European Journal of Histochemistry 65:3.
Crossref
Verena Hofschröer, Karolina Najder, Micol Rugi, Rayhana Bouazzi, Marco Cozzolino, Annarosa Arcangeli, Gyorgy Panyi & Albrecht Schwab. (2021) Ion Channels Orchestrate Pancreatic Ductal Adenocarcinoma Progression and Therapy. Frontiers in Pharmacology 11.
Crossref
Julie Schnipper, Isabelle Dhennin-Duthille, Ahmed Ahidouch & Halima Ouadid-Ahidouch. (2020) Ion Channel Signature in Healthy Pancreas and Pancreatic Ductal Adenocarcinoma. Frontiers in Pharmacology 11.
Crossref
Xiaohui Liu, Hafeez S. Haniff, Jessica L. Childs-Disney, Anton Shuster, Haruo Aikawa, Alexander Adibekian & Matthew D. Disney. (2020) Targeted Degradation of the Oncogenic MicroRNA 17-92 Cluster by Structure-Targeting Ligands. Journal of the American Chemical Society 142:15, pages 6970-6982.
Crossref
Ziyi Li, Weidong Li, Yuqi Dong & Xueying Sun. (2019) Novel Molecular Targets and Mechanisms Involved in the Invasion and Metastasis of Pancreatic Cancer. Clinical Cancer Drugs 6:1, pages 8-20.
Crossref
Yuan Gu, Qijin Feng, Han Liu, Qi Zhou, Ailing Hu, Takuji Yamaguchi, Shilin Xia & Hiroyuki Kobayashi. (2019) Bioinformatic evidences and analysis of putative biomarkers in pancreatic ductal adenocarcinoma. Heliyon 5:8, pages e02378.
Crossref
Jeffery Ho, Xianchun Li, Lin Zhang, Yonghao Liang, Wei Hu, Johnny C.W. Yau, Hung Chan, Tony Gin, Matthew T.V. Chan, Gary Tse & William K.K. Wu. (2019) Translational genomics in pancreatic ductal adenocarcinoma: A review with re-analysis of TCGA dataset. Seminars in Cancer Biology 55, pages 70-77.
Crossref
Jingrong Li, Ruihua Fang, Jianqin Wang & Liehua Deng. (2019) NOP14 inhibits melanoma proliferation and metastasis by regulating Wnt/β-catenin signaling pathway. Brazilian Journal of Medical and Biological Research 52:1.
Crossref
Fabrizio Fierro, Eda Suku, Mercedes Alfonso-Prieto, Alejandro Giorgetti, Sven Cichon & Paolo Carloni. (2017) Agonist Binding to Chemosensory Receptors: A Systematic Bioinformatics Analysis. Frontiers in Molecular Biosciences 4.
Crossref
Bin Zhou, Jian‐Wei Xu, Yu‐Gang Cheng, Jing‐Yue Gao, San‐Yuan Hu, Lei Wang & Han‐Xiang Zhan. (2017) Early detection of pancreatic cancer: Where are we now and where are we going?. International Journal of Cancer 141:2, pages 231-241.
Crossref
E. Giovannetti, C.L. van der Borden, A.E. Frampton, A. Ali, O. Firuzi & G.J. Peters. (2017) Never let it go: Stopping key mechanisms underlying metastasis to fight pancreatic cancer. Seminars in Cancer Biology 44, pages 43-59.
Crossref
Yongxing Du, Ziwen Liu, Lei You, Pengjiao Hou, Xiaoxia Ren, Tao Jiao, Wenjing Zhao, Zongze Li, Hong Shu, Changzheng Liu & Yupei Zhao. (2017) Pancreatic Cancer Progression Relies upon Mutant p53-Induced Oncogenic Signaling Mediated by NOP14. Cancer Research 77:10, pages 2661-2673.
Crossref
Bin Zhou, Hanxiang Zhan, Lamtin Tin, Shanglong Liu, Jianwei Xu, Yanan Dong, Xiaoyu Li, Liqun Wu & Weidong Guo. (2016) TUFT1 regulates metastasis of pancreatic cancer through HIF1-Snail pathway induced epithelial–mesenchymal transition. Cancer Letters 382:1, pages 11-20.
Crossref
Jun-Chao Guo, Jian Li, Li Zhou, Jian-Yu Yang, Zhi-Gang Zhang, Zhi-Yong Liang, Wei-Xun Zhou, Lei You, Tai-Ping Zhang & Yu-Pei Zhao. (2016) CXCL12-CXCR7 axis contributes to the invasive phenotype of pancreatic cancer. Oncotarget 7:38, pages 62006-62018.
Crossref
Yong-Xing Du, Zi-Wen Liu, Lei You, Wen-Ming Wu & Yu-Pei Zhao. (2016) Advances in understanding the molecular mechanism of pancreatic cancer metastasis. Hepatobiliary & Pancreatic Diseases International 15:4, pages 361-370.
Crossref
Nathaniel Weygant, Yang Ge, Dongfeng Qu, John S. Kaddis, William L. Berry, Randal May, Parthasarathy Chandrakesan, Edwin Bannerman-Menson, Kenneth J. Vega, James J. Tomasek, Michael S. Bronze, Guangyu An & Courtney W. Houchen. (2016) Survival of Patients with Gastrointestinal Cancers Can Be Predicted by a Surrogate microRNA Signature for Cancer Stem–like Cells Marked by DCLK1 Kinase. Cancer Research 76:14, pages 4090-4099.
Crossref
Susana Olmedillas López, Dolores García-Olmo, Mariano García-Arranz, Héctor Guadalajara, Carlos Pastor & Damián García-Olmo. (2016) KRAS G12V Mutation Detection by Droplet Digital PCR in Circulating Cell-Free DNA of Colorectal Cancer Patients. International Journal of Molecular Sciences 17:4, pages 484.
Crossref
Jin-Ju Lei, Rou-Jun Peng, Bo-Hua Kuang, Zhong-Yu Yuan, Tao Qin, Wen-Sheng Liu, Yun-Miao Guo, Hui-Qiong Han, Yi-Fan Lian, Cheng-Cheng Deng, Hao-Jiong Zhang, Li-Zhen Chen, Qi-Sheng Feng, Miao Xu, Lin Feng, Jin-Xin Bei & Yi-Xin Zeng. (2015) NOP14 suppresses breast cancer progression by inhibiting NRIP1/Wnt/β-catenin pathway. Oncotarget 6:28, pages 25701-25714.
Crossref
Xiangyu Ma, Liping Guan, Wei Wu, Yao Zhang, Wei Zheng, Yu-Tang Gao, Jirong Long, Na Wu, Long Wu, Ying Xiang, Bin Xu, Miaozhong Shen, Yanhua Chen, Yuewen Wang, Ye Yin, Yingrui Li, Haiwei Xu, Xun Xu & Yafei Li. (2015) Whole-exome sequencing identifies OR2W3 mutation as a cause of autosomal dominant retinitis pigmentosa. Scientific Reports 5:1.
Crossref
E Lastraioli, G Perrone, A Sette, A Fiore, O Crociani, S Manoli, M D'Amico, M Masselli, J Iorio, M Callea, D Borzomati, G Nappo, F Bartolozzi, D Santini, L Bencini, M Farsi, L Boni, F Di Costanzo, A Schwab, A Onetti Muda, R Coppola & A Arcangeli. (2015) hERG1 channels drive tumour malignancy and may serve as prognostic factor in pancreatic ductal adenocarcinoma. British Journal of Cancer 112:6, pages 1076-1087.
Crossref
Jin Feng, Junbo Yu, Xiaolin Pan, Zengliang Li, Zheng Chen, Wenjie Zhang, Bin Wang, Li Yang, Hao Xu, Guoxin Zhang & Zekuan Xu. (2014) HERG1 functions as an oncogene in pancreatic cancer and is downregulated by miR-96. Oncotarget 5:14, pages 5832-5844.
Crossref
Daiki Eguchi, Kenoki Ohuchida, Shingo Kozono, Naoki Ikenaga, Koji Shindo, Lin Cui, Kenji Fujiwara, Shin Akagawa, Takao Ohtsuka, Shunichi Takahata, Shoji Tokunaga, Kazuhiro Mizumoto & Masao Tanaka. (2013) MAL2 expression predicts distant metastasis and short survival in pancreatic cancer. Surgery 154:3, pages 573-582.
Crossref
HoJoon Lee, Billy T. Lau & Hanlee P. Ji. 2013. Next Generation Sequencing in Cancer Research. Next Generation Sequencing in Cancer Research 137 163 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.